21647 ⎘
Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups -
ANTIVIRAL THERAPY
#2702COMPOSITION FOR LIPID DISORDER TREATMENT
#2703PHARMACEUTICAL COMPOSITIONS COMPRISING DEXTROMETHORPHAN AND QUINIDINE FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
#2704TREATMENT OF INFECTIOUS DISEASES
#2705Transplantation Adjuvant in Cell Therapy Using Neural Progenitor Cells
#2706USE OF ISOINDOLES FOR THE TREATMENT OF NEUROBEHAVIORAL DISORDERS
#2707Clonidine and/or clonidine derivatives for use in the prevention of skin injury resulting from radiotherapy
#2708Clonidine and/or clonidine derivatives for use in the prevention and/or treatment of adverse side effects of chemotherapy
#2709Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same
#2710CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER
#2711THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS
#2712PEDIATRIC FORMULATION
#2713TWO CONTAINER SKIN CARE PRODUCT
#2714Inhibitors of MYH7B and uses thereof
#2715Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
#2716Methods for treating allergy and enhancing allergen-specific immunotherapy by administering an antibody to IL-4 receptor
#2717Acylated glucagon analogue
#2718INHIBITION OF AXL/GAS6 SIGNALING IN THE TREATMENT OF LIVER FIBROSIS
#2719Progesterone phosphate analogs and uses related thereto
#2720Pyridazinone compounds and methods for the treatment of cystic fibrosis
#2721Compounds for treatment of cancer
#2722Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#2723Treatment type 2 diabetes mellitus patients
#2724SMALL MOLECULE ENHANCER FOR DENDRITIC CELL CANCER VACCINES
#2725Anti-viral azide containing compounds
#2726Methods for suppressing allergic reactions
#2727Methods used to treat cancer
#2728Specific trifluoroethyl quinoline analogue for use in the treatment of Sjögren's syndrome
#2729Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects
#2730Combination of a PD-1 antagonist and a VEGF-R/FGFR/RET tyrosine kinase inhibitor for treating cancer
#2731Dosage Regimen, Medication Dispensing Package and Uses Thereof for the Treatment of Major Depressive Disorder
#2732Treating or preventing nephrogenic diabetes insipidus
#2733Method of treating renal system damage
#2734GEL COMPOSITION FOR TREATMENT OF COMMON ACNE COMPRISING A COMBINATION OF BENZOYL PEROZIDE AND ADAPALENE AND/OR ADAPALENE SALT
#2735Pharmaceutical quality strontium L-lactate
#2736Pharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4',9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and Paracetamol or Propacetamol
#2737Treatments for attention and cognitive disorders, and for dementia associated with a neurodegenerative disorder
#2738ANTICOAGULANT COMPOUNDS AND THEIR USE
#2739Antimicrobials and methods of use thereof for wound healing
#2740Hydrogel encapsulated cells and anti-inflammatory drugs
#2741DIMETHYL SULFOXIDE (DMSO) AND METHYLSULFONYLMETHANE (MSM) FORMULATIONS TO TREAT OSTEOARTHRITIS
#2742Compositions for topical treatment of microbial infections
#2743PERIODONTAL DISEASE TREATMENT
#2744Composition comprising prostacyclin andor analogues thereof for treatment of acute critically ill patients
#2745Antibody molecules to LAG-3 and uses thereof
#2746Heterocyclic compounds and their use in preventing or treating bacterial infections
#2747Histone deacetylase inhibitors and their use in therapy
#2748Phosphatidylinositol 3-kinase inhibitors
#2749COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS
#2750RORC2 INHIBITORS AND METHODS OF USE THEREOF
#2751Phosphatidylinositol 3-kinase inhibitors
#2752Ethynyl derivatives
#2753Labeled inhibitors of prostate specific membrane antigen (PSMA) biological evaluation, and use of imaging agents
#2754Topical use of levofloxacin for reducing lung inflammation
#2755Therapeutic treatments using centhaquin
#2756Stabilised Solid Compositions of Factor VII Polypeptides
#2757STING (Stimulator of Interferon Genes), A Regulator of Innate Immune Responses
#2758BRAIN AND NEURAL TREATMENTS COMPRISING PEPTIDES AND OTHER COMPOSITIONS
#2759Additives for animal feed
#2760COMPOSITIONS AND METHODS OF TREATING CANCER
#2761Compositions for sensitive skin
#2762CYCLODEXTRIN COMPOUNDS FOR THE PREVENTION AND TREATMENT OF AGING
#2763Composition for curing migraine headaches
#2764Methods of monitoring estriol therapy
#2765Use of aerosolized levofloxacin for treating cystic fibrosis
#2766Use of Morpholino Compounds for the Treatment of Halitosis
#2767INHIBITORS OF BRUTON'S TYROSINE KINASE
#2768COMBINATION OF PANOBINOSTAT AND RUXOLITINIB IN THE TREATMENT OF CANCER SUCH AS A MYELOPROLIFERATIVE NEOPLASM
#2769Salts of quinazoline derivative and method for preparing the same
#2770COMBINATIONS COMPRISING 3-PHENYLSULFONYL-8-PIPERAZINYL-1YL-QUINOLINE
#2771PHARMACEUTICAL COMPOSITIONS COMPRISING AN ANTIPSYCHOTIC DRUG AND A VMAT2 INHIBITOR AND USES THEREOF
#2772NOVEL PHARMACEUTICAL USES
#2773USE OF CHELATORS OF DIVALENT CATIONS TO PROMOTE NERVE REGENERATION
#2774Crystalline compound as semicarbazide-sensitive amine oxidase (SSAO) enzyme inhibitor
#2775Controlled release pharmaceutical formulations of nitozoxanide
#2776Compositions and methods of treating cancer
#2777METHODS FOR TREATING CANCER
#2778METHODS OF TREATING PEDIATRIC METABOLIC SYNDROME
#2779Extended relief dosage form
#2780Altering microbial populations and modifying microbiota
#2781Altering microbial populations and modifying microbiota
#2782METHOD OF INHIBITION OF LEUKEMIC STEM CELLS
#2783Carbidopa and L-dopa prodrugs and methods of use
#2784Fumagillol spirocyclic compounds and fused bicyclic compounds and methods of making and using same
#2785ANTI-PCSK9 COMPOUNDS AND METHODS FOR THE TREATMENT AND/OR PREVENTION OF CARDIOVASCULAR DISEASES
#2786COMBINATION OF CAROTENOIDS AND EPI-LUTEIN
#2787Edible compositions
#2788Methods and compositions for the treatment of symptoms of prion diseases
#2789SYNERGISTIC GLYCOCALYX TREATMENT COMPOSITIONS AND METHODS
#2790ORAL FORMULATIONS FOR PROMOTING CELLULAR PURIFICATION
#2791Antiseptics
#2792METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY AND IMMUNOLOGICAL DISORDERS
#2793Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin
#2794Combination therapy with an antitumor alkaloid
#2795COMBINATION THERAPY WITH AN ANTITUMOR ALKALOID
#2796Compositions of buprenorphine and μ antagonists
#2797Compositions of buprenorphine and μ antagonists
#2798THERAPEUTIC COMPOSITIONS CONTAINING HARMINE AND ISOVANILLIN COMPONENTS, AND METHODS OF USE THEREOF
#2799Compounds and methods for treating influenza
#2800Ocular formulations for drug-delivery and protection of the anterior segment of the eye
#2801Heterocycle analogs of CAI-1 as agonists of quorum sensing in vibrio
#2802ARTICLE OF MANUFACTURE COMPRISING AFLIBERCEPT OR ZIV-AFLIBERCEPT
#2803TRANSDERMAL HORMONE DELIVERY
#2804RNF41 as a biomarker predicting response to lenalidomide in non-del(5q) MDS
#2805Heteroaryl compounds and uses thereof
#2806Inhibitors of histone deacetylase
#2807Compositions and methods for cardiac therapy
#2808Methods and Compositions for the Treatment of Symptoms of Complex Regional Pain Syndrome
#2809Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
#2810ANGIOGENESIS USING PLACENTAL STEM CELLS
#2811COMBINATION OF PHARMACEUTICAL PREPARATIONS FOR TUMOR CHEMOTHERAPY
#2812METHOD AND APPARATUS FOR ESTABLISHING A KEY AGREEMENT PROTOCOL
#2813Methods for the Effective Treatment of Metastatic Cancer
#2814Cyclic boronic acid ester derivatives and methods of making the same
#2815Methods and materials for treating calcific aortic valve stenosis
#2816Vitamin D receptor/SMAD genomic circuit gates fibrotic response
#2817USE OF AGENTS THAT ALTER THE PERITUMORAL ENVIRONMENT FOR THE TREATMENT OF CANCER
#2818Dehydroandrosterol and methods of using the same
#2819COMPOSITIONS AND METHODS FOR TREATING PARKINSON'S DISEASE AND RELATED DISORDERS
#2820SYK INHIBITORS
#2821Use of non-peptide NK1 antagonists in a predetermined dose for the treatment of cancer
#2822COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM
#2823BRUTON'S TYROSINE KINASE INHIBITOR COMBINATIONS AND USES THEREOF
#2824TEC FAMILY KINASE INHIBITOR ADJUVANT THERAPY
#2825Solid pharmaceutical formulation of PARP inhibitors and use thereof
#2826ORAL DOSAGE FORMS FOR OXYGEN-CONTAINING ACTIVE AGENTS AND OXYL-CONTAINING POLYMER
#2827Combinations of Glycopyrrolate and Beta2 Adrenoceptor Agonists
#2828NUTRITIONAL COMPOSITIONS TO ENHANCE MITOCHONDRIAL ENERGY PRODUCTION
#2829THERAPEUTICAL METHODS, FORMULATIONS AND NUTRACEUTICAL FORMULATIONS
#2830Methods of treating dementia and pharmaceutical compositions thereof
#2831COMBINATION OF LBH589 WITH OTHER THERAPEUTIC AGENTS FOR TREATING CANCER
#2832Combination of a PD-1 antagonist and eribulin for treating cancer
#2833Enkephalin-influencing composition and method
#2834Compositions and Methods for Traumatized Tissues Using Zinc Chelators
#2835TREATMENT METHOD FOR IMPROVING INTESTINAL ENVIORNMENT AND INTESTINAL TRACT BARRIER
#2836COMPOSITIONS AND METHODS FOR TREATING ASTHMA AND OTHER LUNG DISEASES
#2837IMMEDIATE RELEASE SOLUBLE IBUPROFEN COMPOSITIONS
#2838Process for manufacturing dry powder blends
#2839Altering microbial populations and modifying microbiota
#2840ANTIBODIES AND METHODS FOR WNT PATHWAY-RELATED DISEASES
#2841Compounds for treating the remyelination blockade in diseases associated with the expression of HERV-W envelope protein
#2842NEW SUBSTITUTED TRIAZOLOPYRIMIDINES AS ANTI-MALARIAL AGENTS
#2843ANTIVIRAL COMPOUNDS
#2844Methods of treating Parkinson's disease
#2845USE OF RANK/RANKL ANTAGONISTS FOR TREATING NEUROMUSCULAR DISORDERS, GENETIC MYOPATHIES AND/OR NON GENETIC MYOPATHIES AND/OR FOR REGULATING SKELETAL AND CARDIAC MUSCLE DISUSE, DISEASES AND AGING
#2846COMBINATION THERAPY OF BISPECIFIC ANTIBODIES SPECIFIC FOR FAP AND DR5 AND CHEMOTHERAPEUTIC AGENTS
#2847Compositions and methods for managing or improving bone disorders, joint disorders, cartilage disorders, or a combination thereof
#2848ANTI-PATHOGENIC COMPOSITIONS
#2849Compositions for use in the treatment of tumors resistant to chemotherapy
#2850Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof
#2851Compositions and methods for treating drug addiction
#2852MAGNESIUM-CONTAINING PRODUCTS AND USES THEREOF
#2853Pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent
#2854Deuterium-Substituted Oxazepin Compounds
#2855IGF-1R signaling pathway inhibitors useful in the treatment of neurodegenerative diseases
#2856Methods for treating intrapulmonary infections
#2857ANTIBACTERIAL COMPOSITIONS
#2858Deuterated analogs of etifoxine, their derivatives and uses thereof
#2859Modulators of Androgen Synthesis
#2860ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE
#2861Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
#2862IMMEDIATE RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING OXYCODONE AND NALOXONE
#2863Method of treating pulmonary arterial hypertension
#2864Nintedanib diethanesulfonate salt crystal and preparation method and use thereof
#2865THERAPEUTIC COMBINATIONS OF CURCUMINOIDS AND FLAVONOIDS
#2866Derivatives of korormicin useful as antibiotics
#2867Methods of treating or preventing prostate cancer
#2868Methods and compositions for improving microvascular function, suppressing cyclooxygenase activity, reducing platelet aggregation and increasing levels of resveratrol in plasma
#2869NOVEL COMPOSITIONS AND USES OF METFORMIN AGENTS
#2870AMINO ALCOHOL DERIVATIVES FOR THE TREATMENT OF DEMYELINATING PERIPHERAL NEUROPATHIES
#2871Bisphenol ether derivatives and methods for using the same
#2872PLATFORM DRUG DELIVERY SYSTEM UTILIZING CRYSTAL ENGINEERING AND THEANINE DISSOLUTION
#2873Compositions and methods for inhibiting hair growth
#2874Altering microbial populations and modifying microbiota
#2875Altering microbial populations and modifying microbiota
#2876MOLECULAR TARGETS FOR THE PREVENTION AND/OR TREATMENT OF FIBROSIS, HYPERTROPHIC SCARS OR KELOIDS
#2877METHODS OF TREATING MENINGIOMA
#2878Anti-histone therapy in acute kidney injury
#2879Compositions and methods for inhibiting kinases
#2880Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
#2881Iron garnet nanoparticles for cancer radiotherapy and chemotherapy
#2882COMPOSITIONS AND METHODS FOR INCREASING LIFESPAN AND HEALTH SPAN
#2883COMPOSITIONS AND METHODS FOR ENHANCING THE THERAPEUTIC POTENTIAL OF STEM CELLS
#2884Fast acting joint relief formulations
#2885Nutritional composition or pharmaceutical and dietary supplement containing said nutritional or pharmaceutical composition
#2886NUTRITIONAL FORMULATIONS INCLUDING HUMAN MILK OLIGOSACCHARIDES AND ANTIOXIDANTS AND USES THEREOF
#2887Heterocyclic compounds and uses thereof
#2888METHODS OF TREATING CANCER USING 3-(5-AMINO-2-METHYL-4-OXO-4H-QUINAZOLIN-3-YL)-PIPERIDINE-2,6-DIONE
#2889Kinase modulation, and indications therefor
#2890Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infections
#2891Treatment for ischemic stroke
#2892Materials and methods for controlling infections
#2893Materials and methods for controlling infections
#2894Immediate release oral guaifenesin solution
#2895Preparations having a cooling effect
#2896Compound inhibiting activities of BTK and/or JAK3 kinases
#2897Compounds and compositions for inhibition of FASN
#2898RUFINAMIDE AND DERIVATIVES AND THEIR USE IN MODULATING THE GATING PROCESS OF HUMAN VOLTAGE-GATED SODIUM CHANNELS
#2899Pharmaceutical compositions containing taxane-cyclodextrin complexes, method of making and methods of use
#2900COMPOSITIONS AND METHODS FOR SENSITIZING CELLS TO TRAIL-INDUCED APOPTOSIS
#2901Ophthalmic compositions and methods of use therefor
#2902ANGIOTENSIN PEPTIDES IN TREATING MARFAN SYNDROME AND RELATED DISORDERS
#2903Roneparstat combined therapy of multiple myeloma
#2904Induction of tumor hypoxia for cancer therapy
#2905Treatment of Multiple Sclerosis With Combination of Laquinimod and Dimethyl Fumarate
#2906SELECTIVE CONNEXIN HEMICHANNELS BLOCKERS FOR THE TREATMENT OF EPILEPSY
#2907Oxybutynin-xanomeline transdermal therapeutic system combinations
#2908Pharmaceutical combination comprising metformin and dihydroquercetin and its use for the treatment of cancer
#2909Method for Inhibiting Growth of Ovarian Cancer Cells
#2910Oxybutynin transdermal therapeutic system muscarinic agonist combination
#2911COMPOSITIONS AND METHODS OF TREATMENT OF BREAST DISORDERS AND ESTROGEN-RELATED DISORDERS
#2912Liquisoft capsules
#2913Cosmetic Compostions
#2914Preparations
#2915Tricyclic benzoxaborole compounds and uses thereof
#2916Phthalazinone compounds and methods for the treatment of cystic fibrosis
#2917Method of treating or preventing Ras-mediated diseases
#2918Azepane derivatives and methods of treating hepatitis B infections
#2919Dual function molecules for histone deacetylase inhibition and ataxia telangiectasia mutated activation and methods of use thereof
#2920Stabilized polymeric carriers for therapeutic agent delivery
#2921Compositions Using Antibodies Directed to GPNMB and Uses Thereof
#2922TREATMENT OF SOCIAL ANXIETY DISORDER, OBSESSIVE COMPULSIVE DISORDER AND PANIC DISORDER USING BOTULINUM TOXIN
#2923IMMUNOMODULATORY COMPOSITIONS
#2924PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER
#2925SANDALWOOD OIL AND ITS USES
#2926Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#2927Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
#2928Polymer matrix compositions comprising a high concentration of bio-fermented sodium hyaluronate and uses thereof
#2929ANTIBACTERIAL INJECTABLE PHARMACEUTICAL COMPOSITION
#2930Glucocerebroside treatment of liver disorders
#2931CABAZITAXEL AND ITS USE FOR TREATING METASTATIC PROSTATE CANCERS
#2932NOVEL COMPOSITIONS OF COMBINATIONS OF NON-COVALENT DNA BINDING AGENTS AND ANTI-CANCER AND/OR ANTI-INFLAMMATORY AGENTS AND THEIR USE IN DISEASE TREATMENT
#2933MAINTENANCE THERAPY USING TIANEPTINE
#2934USE OF SUBSTITUTED 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINES
#2935COMBINATIONS COMPRISING BREXPIPRAZOLE OR A SALT THEREOF AND A SECOND DRUG FOR USE IN THE TREATMENT OF A CNS DISORDER
#2936Drug compositions comprising an anti-parasitic and proton pump inhibitor
#2937Method of Treating Transplant Rejection and Autoimmune Diseases
#2938V1B RECEPTOR ANTAGONIST FOR USE IN THE TREATMENT OF PATIENTS HAVING AN ELEVATED AVP LEVEL AND/OR AN ELEVATED COPEPTIN LEVEL
#2939Use of amisulpride as an anti-emetic
#2940Compositions and methods for lowering levels of high-sensitivity C-reactive protein (hs-CRP) in a subject
#2941Free amino acid preparation and uses thereof
#2942USE OF CYSTEAMINE AND DERIVATIVES THEREOF TO SUPPRESS TUMOR METASTASES
#2943THERAPEUTIC AGENTS FOR USE IN THE PROPYLAXIS AND/OR TREATMENT OF HYPERKINETIC MOVEMENT DISORDERS
#2944Antimicrobial compositions
#2945Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
#2946COMPOSITIONS AND METHODS FOR EFFICACIOUS AND SAFE DELIVERY OF SIRNA USING SPECIFIC CHITOSAN-BASED NANOCOMPLEXES
#2947Methods for treating refractory anemia with ringed sideroblasts
#2948Thienodiazepine derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition including the same as an active ingredient
#2949Prodrugs of riluzole and their method of use
#2950Isothiocyanate functional surfactants, formulations incorporating isothiocyanate functional surfactants and associated methods for treating biofilms
#2951Drug releasing coatings for balloon catheters
#2952COUPLED IDENTIFICATION AND TREATMENT OF CANCER
#2953Dodecafluoropentane emulsion as a stroke and ischemia therapy
#2954FORMULATIONS FOR ORAL ADMINISTRATION OF ACTIVE AGENTS WITH CONTROLLED ABSORPTION PROFILE
#2955Treatments for migraine and related disorders
#2956Methods for treating metabolic disorders using FGF
#2957ADMINSTRATION OF RECOMBINANT COLLAGEN 7 FOR THE TREATMENT OF AGE RELATED DISORDERS
#2958Compositions and methods for treatment of pain
#2959COMPOSITIONS AND METHODS OF TREATING VIRAL INFECTIONS
#2960Cell preparations for extemporaneous use, useful for healing and rejuvenation in vivo
#2961EXPANSION OF ALLOANTIGEN-REACTIVE REGULATORY T CELLS
#2962Increasing the half-life of hydrogen peroxide in an ingestible composition
#2963Topical and oral formulations comprising taurine and magnesium for the prevention and treatment of acne
#2964L-ARABINOSE PLUS CHROMIUM FOR CONTROLLING THE METABOLIZATION OF SUCROSE
#2965Riluzole prodrugs and their use
#2966Methods and compositions for reversing disruption of the glycocalyx, inflammation, and oxidative damage
#2967Pharmaceutical for prophylaxis or treatment of hypertension
#2968PHARMACEUTICAL COMBINATION COMPRISING METFORMIN AND DIHYDROQUERCETIN AND ITS USE FOR THE TREATMENT OF CANCER
#2969Combination comprising N-acetyl-L-cysteine and its use
#2970Combination of a retinoid and a diol and polyunsaturated fatty acid ester
#2971Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
#2972Method and medicines for treating melanoma
#2973ZEAXANTHIN FOR TUMOR TREATMENT
#2974PREVENTION OF AND RECOVERY FROM DRUG-INDUCED OTOTOXICITY
#2975HYALURONIC ACID PARTICLES FOR COSMETIC OR DERMATOLOGICAL USES
#2976Regulation of Autophagy and Cell Survival
#2977Quinazolinone antibiotics
#2978Liquid formulation
#2979DRUG COMBINATIONS COMPRISING A DGAT INHIBITOR AND A PPAR-AGONIST
#2980METHODS OF INDUCING INDOLAMINE 2,3 - DIOXYGENASE (IDO)
#2981Methods of treatment for retinal diseases using MANF and CNDF
#2982Compostions for Treating Dry Eye Disease
#2983Cancer therapy with a parvovirus combined with bevacizumab
#2984Method for preparing a liposomal rehydration salt formulation
#2985Methods of treating optic disorders
#2986Use of Flecainide as an Anti-Connexin Agent and Method for Potentiating the Effects of a Psychotropic Drug
#2987Benzimidazole sulfide derivatives for the treatment or prevention of tuberculosis
#2988Substituted quinolizine derivatives useful as HIV integrase inhibitors
#2989Use of 2,5-dihydroxybenzene compounds and derivatives for the treatment of glioma
#2990Fine Dry Particulate Retinoid Active Agent Compositions and Topical Formulations Including the Same
#2991Composition with insect repellent activity
#29923.beta-hydroxysteroid dehydrogenase in steroid dependent disease
#2993IMMUNE REGULATORY OLIGONUCLEOTIDE (IRO) COMPOUNDS TO MODULATE TOLL-LIKE RECEPTOR BASED IMMUNE RESPONSE
#29943-substituted cyclopentylamine derivatives
#2995Crystalline forms of (S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide
#2996Small-molecule inhibitors targeting discoidin domain receptor 1 and uses thereof
#2997Substituted quinoxalines for inhibiting kinase activity
#2998Drug releasing coatings for medical devices
#2999Composition comprising hyaluronic acid and mepivacaine
#3000Methods for treating back or neck pain caused by NGF using a therapeutic agent comprising REN-1820, ALE-0540 and capsaicin